SkinHealth Systems said the U.S. FDA cleared its SkinStylus microneedling device for improving periorbital wrinkles in adults aged 22+ across all Fitzpatrick skin types. The clearance expands the device’s approved use profile, which is supportive for product adoption. No financial guidance or revenue figures were provided.
SkinHealth Systems said the U.S. FDA cleared its SkinStylus microneedling device for improving periorbital wrinkles in adults aged 22+ across all Fitzpatrick skin types. The clearance expands the device’s approved use profile, which is supportive for product adoption. No financial guidance or revenue figures were provided.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment